VATE
Get informed when a big investor buys or sells
+ FollowOvervalued by 232.7% based on the discounted cash flow analysis.
| Market cap | $102.31 Million |
|---|---|
| Enterprise Value | $206.81 Million |
| Dividend Yield | $0.78 (10.40%) |
| Earnings per Share | $-4.84 |
| Beta | 2.35 |
| Outstanding Shares | 13,374,803 |
| P/E Ratio | -4.08 |
|---|---|
| PEG | 2.65 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 3.75 |
| Enterprise Value to Revenue | 0.14 |
| Enterprise Value to EBIT | -13.88 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 3.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 23.53%▲ 5.55% |
|---|---|
| Total Invested | $58.77M▲ 331.05% |
| Investors Holding | 50▲ 19.00% |
No data
HC2 Holdings, Inc.has a class-leading portfolio of assets primarily in Infrastructure, Life Sciences, Spectrum and Insurance. HC2 is headquartered in New York, New York and through its subsidiaries employs more than 2,800 people.